Ticker: PRAX

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders. Here's an overview of the company's performance in the second quarter of 2025, highlighting key aspects of their income stateme...